Marjolaine Tremblay

TL;DR: Simple measurement of serum PSA can be used efficiently as a pre-screening test for prostate cancer in the general population to identify, at a low cost, the subpopulation of men at a much greater risk of having prostate cancer, and who should then be submitted to the more elaborate and expensive diagnostic procedures.

TL;DR: The cases reported so far indicate that the incidence of flutamide-induced liver toxicity is very low, and serial blood aminotransferase measurements are recommended at 2 and 4 weeks of treatment in order to detect early signs of possible flutamia-induced hepatic injury, thus avoiding the low potential risk of clinically significant liver toxicity.

TL;DR: The present data indicate that Oestrogel provides efficient relief of climacteric and urogenital symptoms without exerting any detectable effect on hepatic function while maintaining the ratio of serum E2/E1 at the physiological value of 1.0.

TL;DR: Serial serum prostatic acid phosphatase (PAP) and prostate specific antigen (PSA) measurements are performed in 871 patients treated with hormonal combination therapy for stage C and D prostate cancer patients treated by combination endocrine therapy and they show that serum PSA measurements are superior to those of serum PAP for predicting disease recurrence.

TL;DR: A 69-year-old patient treated for stage C adenocarcinoma of the prostate with the combination of the luteinizing hormone-releasing hormone agonist and the antiandrogen nilutamide who developed simultaneous liver and lung toxicity is reported.